Geode Capital Management’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4M | Buy |
1,940,824
+644,840
| +50% | +$4.89M | ﹤0.01% | 2175 |
|
|
2026
Q1 | $9.33M | Buy |
1,295,984
+28,592
| +2% | +$184K | ﹤0.01% | 2420 |
|
|
2025
Q4 | $7.15M | Sell |
1,267,392
-19,851
| -2% | -$108K | ﹤0.01% | 2572 |
|
|
2025
Q3 | $7.94M | Sell |
1,287,243
-222,910
| -15% | -$1.3M | ﹤0.01% | 2546 |
|
|
2025
Q2 | $7.36M | Buy |
1,510,153
+979,294
| +184% | +$3.46M | ﹤0.01% | 2537 |
|
|
2025
Q1 | $1.96M | Buy |
530,859
+21,057
| +4% | +$90.2K | ﹤0.01% | 3039 |
|
|
2024
Q4 | $2.04M | Buy |
509,802
+4,932
| +1% | +$27.1K | ﹤0.01% | 3115 |
|
|
2024
Q3 | $3.52M | Sell |
504,870
-8,616
| -2% | -$69.9K | ﹤0.01% | 2929 |
|
|
2024
Q2 | $2.91M | Buy |
513,486
+275,813
| +116% | +$2.47M | ﹤0.01% | 2998 |
|
|
2024
Q1 | $3.17M | Buy |
237,673
+144,172
| +154% | +$1.35M | ﹤0.01% | 2926 |
|
|
2023
Q4 | $574K | Sell |
93,501
-9,012
| -9% | -$28.8K | ﹤0.01% | 3557 |
|
|
2023
Q3 | $258K | Buy |
102,513
+13,254
| +15% | +$51.4K | ﹤0.01% | 3876 |
|
|
2023
Q2 | $468K | Buy |
89,259
+47,348
| +113% | +$266K | ﹤0.01% | 3673 |
|
|
2023
Q1 | $199K | Buy |
41,911
+2,830
| +7% | +$17K | ﹤0.01% | 4055 |
|
|
2022
Q4 | $210K | Sell |
39,081
-2,944
| -7% | -$19.3K | ﹤0.01% | 4072 |
|
|
2022
Q3 | $294K | Buy |
42,025
+202
| +0.5% | +$2.04K | ﹤0.01% | 4000 |
|
|
2022
Q2 | $386K | Sell |
41,823
-28,048
| -40% | -$291K | ﹤0.01% | 3901 |
|
|
2022
Q1 | $1.26M | Buy |
69,871
+1,733
| +3% | +$30.6K | ﹤0.01% | 3507 |
|
|
2021
Q4 | $1.79M | Buy |
68,138
+634
| +0.9% | +$19.4K | ﹤0.01% | 3419 |
|
|
2021
Q3 | $2.42M | Sell |
67,504
-6,098
| -8% | -$259K | ﹤0.01% | 3267 |
|
|
2021
Q2 | $4.04M | Buy |
73,602
+37,392
| +103% | +$2.47M | ﹤0.01% | 3028 |
|
|
2021
Q1 | $3M | Buy |
36,210
+5,032
| +16% | +$557K | ﹤0.01% | 3051 |
|
|
2020
Q4 | $3.54M | Buy |
31,178
+7,795
| +33% | +$493K | ﹤0.01% | 2778 |
|
|
2020
Q3 | $712K | Buy |
23,383
+745
| +3% | +$28.5K | ﹤0.01% | 3320 |
|
|
2020
Q2 | $994K | Buy |
22,638
+2,925
| +15% | +$121K | ﹤0.01% | 3138 |
|
|
2020
Q1 | $706K | Buy |
19,713
+1,365
| +7% | +$67.6K | ﹤0.01% | 3152 |
|
|
2019
Q4 | $1.22M | Buy |
18,348
+3,031
| +20% | +$334K | ﹤0.01% | 3208 |
|
|
2019
Q3 | $2.38M | Buy |
15,317
+2,066
| +16% | +$234K | ﹤0.01% | 2835 |
|
|
2019
Q2 | $1.14M | Buy |
13,251
+1,070
| +9% | +$117K | ﹤0.01% | 3196 |
|
|
2019
Q1 | $1.68M | Buy |
12,181
+975
| +9% | +$244K | ﹤0.01% | 2954 |
|
|
2018
Q4 | $4.5M | Buy |
11,206
+2,271
| +25% | +$1.07M | ﹤0.01% | 2281 |
|
|
2018
Q3 | $6.32M | Buy |
8,935
+3,481
| +64% | +$2.19M | ﹤0.01% | 2211 |
|
|
2018
Q2 | $2.92M | Buy |
5,454
+1,469
| +37% | +$452K | ﹤0.01% | 2633 |
|
|
2018
Q1 | $448K | Buy |
+3,985
| New | +$1.35M | ﹤0.01% | 3443 |
|
Other funds holding SLDB
RCM
PA
BCLSI
SL
AC
JT
Geode Capital Management's SLDB Position: Q2 2026 in Review
Geode Capital Management increased its Solid Biosciences (SLDB) stake by 50% in Q2 2026, buying an estimated $4.89M and bringing the position to 1,940,824 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.
Geode Capital Management first reported a position in SLDB in Q1 2018 and has held it in 34 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.
- Geode Capital Management held 1,940,824 shares of Solid Biosciences worth $19.4M as of Q2 2026.
- Geode Capital Management bought 644,840 Solid Biosciences shares in Q2 2026, an estimated $4.89M.
- Solid Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2175 holding.
- Geode Capital Management first reported a position in Solid Biosciences in Q1 2018 and has held it in 34 quarters since.
- 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.